Strongbridge Biopharma Plc (SBBP) Return on Equity ROE from the second quarter 2021 to second quarter 2020 and annually, average high and low, overall ranking from Jun 30 2021 to Jun 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Strongbridge Biopharma plc  (NASDAQ: SBBP)

Strongbridge Biopharma Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Strongbridge Biopharma Plc in the second quarter 2021?
Strongbridge Biopharma Plc recorded a cumulative net loss of $-40 million during 12 months ending in the second quarter 2021, resulting in a negative return on equity (ROE) of -66.82%.

Within the Major Pharmaceutical Preparations industry 284 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2021 from 0 to 3857.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter
Y / Y Equity Change -7.27 % -8.72 % -9.12 % -6.37 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -40 -44 -45 -42 -53
Return On Equity (TTM) -66.82 % -72.48 % -72.35 % -65.84 % -80.86 %
SBBP's Total Ranking # 3857 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 44 56 66 75 48
Seq. Equity Change -20.51 % -14.87 % -12.02 % 55.78 % -21.76 %
Seq. Net Income Change - - - - -

Back to SBBP Management Effectiveness >> SBBP's 5 Years Annual ROE >> Compare SBBP ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 285
Sector # 615
Overall # 3857

Return On Equity Statistics
High Average Low
108.51 %
-224.13 %
-2682.81 %
(Dec 31 2018)   (Dec 31 2017)





SBBP Annual Return On Equity (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Equity in Millions 66 72 113 -12 67
Y / Y Equity Change -9.12 % -36.09 % - - -26.35 %
Net Income in Millions -45 -49 32 -113 -49
Y / Y Net Income Change - - - - -
Return On Equity -68.71 % -68.5 % 28.2 % - -72.75 %

Back to SBBP Management Effectiveness >> SBBP's 5 Years Annual ROE >> Compare SBBP ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SBBP's' Return on Equity at Yahoo Finance
SBBP's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SBBP's Competitors
Subscribers only: Roe for Strongbridge Biopharma Plc's Suppliers
Subscribers only: Return On Equity for SBBP's Customers




Companies with similar Return On Equity at Jun 30 2021, within Healthcare Sector ROE

Date modified: 2026-09-08T15:10:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.